Zobrazeno 1 - 5
of 5
pro vyhledávání: '"E. P. Pankratenko"'
Autor:
Aleksey Evgenievich Petukhov, Valentin Yurievich Skryabin, Elena A. Grishina, Alexander S. Sorokin, Mikhail Sergeevich Zastrozhin, Dmitry A. Sychev, E. A. Bryun, Valery V. Smirnov, Ludmila M. Savchenko, Kristina Anatolievna Ryzhikova, E. P. Pankratenko, Aleksey Sergeevich Panov
Publikováno v:
Pharmacogenomics. 21:449-457
Phenazepam® is prescribed to relieve anxiety and sleep disorders during alcohol withdrawal, although it is associated with undesirable side effects. Aim: To demonstrate changes in the safety and efficacy profiles of Phenazepam in patients with anxie
Autor:
M S, Zastrozhin, A V, Efimova, VYu, Skryabin, V V, Smirnov, A E, Petukhov, E P, Pankratenko, S A, Pozdniakov, E V, Kaverina, D A, Klepikov, E A, Grishina, K A, Ryzhikova, I V, Bure, E A, Bryun, D A, Sychev
Publikováno v:
Psychopharmacol Bull
INTRODUCTION: Phenazepam is commonly administered to patients diagnosed with major depressive disorder. Some proportion of such patients do not show adequate response to treatment regimen containing phenazepam, whereas many of them experience type A
Autor:
M S, Zastrozhin, V Yu, Skryabin, A E, Petukhov, M V, Torrado, E P, Pankratenko, A K, Zastrozhina, E A, Grishina, K A, Ryzhikova, V V, Shipitsyn, E A, Bryun, D A, Sychev
Publikováno v:
The pharmacogenomics journal. 21(4)
Citalopram is commonly prescribed to patients suffering from major depressive disorder. Some of them do not respond adequately to therapy with citalopram, while many of them experience type A adverse drug reactions. Current research revealed that CYP
Autor:
Pavel Golovinskii, Elena A. Grishina, K. A. Ryzhikova, S. G. Koporov, Mikhail Sergeevich Zastrozhin, Dmitry A. Sychev, A. K. Zastrozhina, I V Bure, V.Yu. Skryabin, Alexey E. Petukhov, V. V. Smirnov, E. P. Pankratenko, E. A. Bryun
Publikováno v:
Gene. 739
Alprazolam is used in the treatment of patients with anxiety disorders comorbid with alcohol use disorder. Some proportion of these patients does not respond adequately to treatment with alprazolam, while many of them experience dose-dependent advers
Autor:
Pavel Golovinskii, Mikhail Sergeevich Zastrozhin, Andrey V Ivanov, E. A. Bryun, E. A. Grishina, V. V. Smirnov, E. P. Pankratenko, Alexey E. Petukhov, K. A. Ryzhikova, I V Bure, D. A. Sychev, A. K. Zastrozhina, S. G. Koporov
Publikováno v:
SSRN Electronic Journal.
Introduction: Sertralineis commonly administered topatients with depressive disorders comorbid with alcohol use disroder. Some part of such patients do not respond adequately to treatment regimen containing sertraline, whereas many of them experience